Search clinical trials for: Modulation of FiO2

Total 10000 results

Xinhua Hospital, Shanghai Jiao Tong University...
Novartis

Unknown

Pre-vitrectomy Intravitreal Ranibizumab for Patients With Proliferative Diabetic Retinopathy Combined With Diabetic Macular Edema

Diabetic Macular Edema | Proliferative Diabetic Retinopathy

China
Mazandaran University of Medical Sciences

Completed

Thrombolysis Outcome in Ischemic Stroke (TOSSI)

Mortality | Stroke, Acute | Thrombolytic Therapy | Alteplase

Iran, Islamic Republic of
Metaxa Hospital

Unknown

Metaxa Hospital THromboprophylaxis Program in Oncological & Surgical Patients (MeTHOS)

Thrombosis | Solid Cancer

Greece
Federico II University

Completed

Evaluation of Retinal and Vascular Features in Macular Degeneration After Intravitreal Injections of Bevacizumab

Exudative Age-related Macular Degeneration

Italy
Bayer
Regeneron Pharmaceuticals

Completed

Special Drug Use Investigation of EYLEA for Myopic Choroidal Neovascularization

Choroidal Neovascularization

Japan
Unity Health Toronto

Completed

Predictors of Treatment Response to Aflibercept and Aqueous Cytokine Levels in Diabetic Macular Edema

Diabetic Macular Edema

Canada
Alcon Research
Novartis Institutes for BioMedical Research

Terminated

Safety Tolerability and Efficacy of Intravitreal LMG324 in the Treatment of Neovascular Age-Related Macular Degeneration

Age-related Macular Degeneration (AMD)

United States
Queen's University
The Physicians' Services Incorporated Foundation

Completed

Bloodstream Absorption of Avastin and Lucentis After Injection Into the Eye

Diabetic Macular Edema

Canada
Hospices Civils de Lyon

Completed

French Evaluation Group Avastin Versus Lucentis (GEFAL)

Age Related Macular Degeneration

France
University of Utah

Completed

Real-time Anti-Factor Xa Measurements in Surgical Patients to Examine Enoxaparin Metabolism and Optimize Enoxaparin Dose

Venous Thromboembolism | Deep Venous Thrombosis | Pulmonary Embolus

United States
Case Comprehensive Cancer Center
University of Cincinnati; OhioHealth Research Institute

Completed

Feasibility Trial of the Modified Atkins Diet and Bevacizumab for Recurrent Glioblastoma

Glioblastoma | Brain Tumor

United States
The University of Texas Health Science Center,...
University Hospitals Cleveland Medical Center; University of Arkansas; Ochsner...

Terminated

Propaten Randomized Investigation on Cost-benefit and Efficacy (PRICE)

End-stage Renal Disease

United States
Bayer
Regeneron Pharmaceuticals

Completed

To Describe the Use of Intravitreal Aflibercept and to Describe Follow-up as Well as Treatment Patterns in Patients With Wet Age-related Macular Degeneration (wAMD) or Diabetic Macular Edema (DME) in Routine Clinical Practice in Canada. (PEGASUS)

Wet Macular Degeneration

Canada
China International Medical Foundation
Chinese Society of Clinical Oncology

Unknown

A Trial of Endostar in Patients With Carcinoma of the Head and Neck

Nasopharyngeal Neoplasms

China
Dr. med. Lars-Olof Muegge

Terminated

Treatment Optimization in Patients With Untreated Multiple Myeloma (GERMAIN)

Multiple Myeloma

Germany
Hoffmann-La Roche

Withdrawn

A Study of Atezolizumab in Combination With Bevacizumab in Untreated Locally Advanced or Metastatic Clear Cell or Non-Clear Cell Renal Cell Carcinoma

Renal Cell Carcinoma
Singapore General Hospital
National University Hospital, Singapore; National Cancer Center Singapore,... and other collaborators

Withdrawn

Study Of Durvalumab and Lenalidomide In R/R EBV Associated DLBCL Subtypes, Primary CNS And Testicular DLBCL (DuRIANS)

EBV Related Non-Hodgkin's Lymphoma | Primary CNS Lymphoma | Primary Testicular Lymphoma

Singapore
Georgetown University

Terminated

Ph 2 Study of TAS-102 / Bevacizumab Maintenance Therapy Post Induction Chemotherapy in Metastatic Colorectal Cancer (ALEXANDRIA)

Metastatic Colorectal Cancer

United States
Bayer
Regeneron Pharmaceuticals

Completed

EYLEA [AMD-QOL(Age-Related Macular Degeneration-Quality of Life)] Post-marketing Surveillance in Japan

Macular Degeneration

Japan
Bayer
Regeneron Pharmaceuticals

Completed

Investigating the Effectiveness of Eylea in Patients With Wet Age-related Macular Degeneration (PERSEUS)

Wet Age-related Macular Degeneration

Germany
Vista Klinik

Completed

SD-OCT-guided Intravitreal Ranibizumab Treatment in Choroidal Neovascularization Due to Myopia

Age Related Macular Degeneration | Choroidal Neovascularization

Switzerland
Northern California Retina Vitreous Associates
Regeneron Pharmaceuticals

Completed

NEWTON: Aflibercept Injection for Previously Treated Macular Edema Associated With Central Retinal Vein Occlusions (NEWTON)

Macular Edema With Central Retinal Vein Occlusions

United States
Toni Choueiri, MD
Beth Israel Deaconess Medical Center

Completed

Bevacizumab and BKM-120 in Patients With Metastatic Renal Cell Carcinoma

Renal Cell Carcinoma

United States
National Heart, Lung, and Blood Institute (NHLBI)

Completed

Thrombolysis in Myocardial Ischemia Trial (TIMI III)

Myocardial Infarction | Myocardial Ischemia | Heart Diseases | Cardiovascular Diseases | Coronary Disease | Angina Pectoris
University of Rochester
National Heart, Lung, and Blood Institute (NHLBI); Eisai Inc.

Terminated

A Study of Dalteparin Prophylaxis in High-Risk Ambulatory Cancer Patients (PHACS)

Venous Thromboembolism | Pulmonary Embolism

United States, Canada
Allergan

Completed

A Study of Abicipar Pegol in Patients With Diabetic Macular Edema

Macular Edema

United States
Johns Hopkins University

Completed

Intraventricular Rt-PA in Patients With Intraventricular Hemorrhage

Cerebral Hemorrhage

United States
Ottawa Hospital Research Institute
LEO Pharma

Completed

A Comparison of Dalteparin and Tinzaparin for Prevention of Blood Clots in Hemodialysis Patients on Oral Anticoagulants Having Surgery

Hemodialysis | Thromboembolism

Canada
Hoffmann-La Roche

Terminated

A Study of Avastin (Bevacizumab) in Patients With Multiple Myeloma

Multiple Myeloma

Austria
Ottawa Hospital Research Institute
Canadian Institutes of Health Research (CIHR)

Completed

TIPPS: Thrombophilia in Pregnancy Prophylaxis Study (TIPPS)

Pregnancy Complications | Pregnancy | Thrombophilia

Canada, United States
Duke University
Genentech, Inc.

Completed

Radiosurgery and Avastin for Recurrent Malignant Gliomas

Malignant Glioma

United States
Ahi Evren Chest and Cardiovascular Surgery Education...

Unknown

Low Dose Prolonged Infusion of Tissue Type Plasminogen Activator Therapy in Massive Pulmonary Embolism

Pulmonary Embolism

Turkey
Novartis

Completed

Efficacy and Safety of Ranibizumab (Intravitreal Injections) in Patients With Visual Impairment Due to Diabetic Macular Edema (REVEAL)

Diabetic Macular Edema

Hong Kong, Taiwan, Singapore, Korea, Republic of, China, Japan
Sivakami A Pai

Unknown

Efficacy and Safety of Intravitreal Bevacizumab for Threshold ROP.

Stage 2+ or Stage 3+ Retinopathy of Prematurity in Zone I or Zone II.

United Arab Emirates
CSL Behring

Completed

A Study of Factor XIII Concentrate in Subjects With Congenital Factor XIII Deficiency

Factor XIII Deficiency

United States, Spain
Alcon Research

Withdrawn

A Multi-Dose Study With a Treatment for Open-Angle Glaucoma

Open-Angle Glaucoma
Anders Kvanta

Completed

Bevacizumab for Central Retinal Vein Occlusion Study

Central Retinal Vein Occlusion

Sweden
University Hospital Inselspital, Berne
Novartis

Completed

Immediate Effects of Lucentis® in Conjunction With Photodynamic Therapy With Visudyne® in Exudative AMD(IECOMB)

Age Related Macular Degeneration

Switzerland
Azienda Ospedaliera Universitaria Policlinico

Unknown

Residual Vein Thrombosis and the Optimal Duration of Low Molecular Weight Heparin in Cancer Patients With Deep Vein Thrombosis (Cancer-DACUS)

Cancer | Deep Vein Thrombosis

Italy
Shahid Beheshti University of Medical Sciences

Completed

Intravitreal Bevacizumab for Neovascular Glaucoma (IVB NVG)

Glaucoma | Neovascular

Iran, Islamic Republic of
Tongji Hospital

Recruiting

Pyrotinib Combined With Capecitabine and Bevacizumab for Patients With HER2 Positive Breast Cancer and Brain Metastases

Breast Cancer With Brain Metastases

China
CHA University
Boryung Pharmaceutical Co., Ltd

Recruiting

Predictive Biomarkers in Patients With Advanced Hepatocellular Carcinoma Treated With Atezolizumab Plus Bevacizumab (HCC)

Advanced Hepatocellular Carcinoma

Korea, Republic of
Federation Francophone de Cancerologie Digestive

Recruiting

Study to Evaluate Efficacy and Safety of Selective Internal Radiation Therapy Plus Xelox, Bevacizumab and Atezolizumab (Immune Chekpoint Inhibitor) in Patients With Liver-dominant Metastatic Colorectal Cancer (SIRTCI)

Metastatic Colorectal Cancer | MSS | pMMR | Immune Checkpoint Inhibitor | Internal Radiotherapy

France
City of Hope Medical Center

Completed

Predicting the Efficacy in Advanced Gastric Cancer.

Gastric Cancer | Chemotherapy Effect | Ramucirumab | Paclitaxel

Japan, United States
Dana-Farber Cancer Institute
Genentech, Inc.

Completed

Study of Atezolizumab + Bevacizumab in Patients With Advanced Non-Clear Cell Renal Cell Carcinoma

Advanced Non-Clear Cell Kidney Cancer

United States
M.D. Anderson Cancer Center

Withdrawn

A Study Evaluating Atezolizumab and Bevacizumab Plus ADI-PEG 20 in Patients With Locally Advanced / Metastatic Hepatocellular Carcinoma

Metastatic Hepatocellular Carcinoma

United States
Hackensack Meridian Health
Celgene Corporation

Terminated

Study Examining the Combination of Revlimid (Lenalidomide)and Vidaza (Azacitidine) for Relapsed/Refractory CLL and SLL (VZCLLPI0146)

Small Lymphocytic Lymphoma | Chronic Lymphocytic Leukemia(CLL)

United States
Dana-Farber Cancer Institute
Bayer; Pfizer

Completed

Phase Ib Study of SUnitinib Alternating With REgorafenib in Patients With Metastatic and/or Unresectable GIST (SURE)

Gastrointestinal Stromal Tumor

United States
Cliniques universitaires Saint-Luc- Université...

Terminated

Evaluation of Predictive Markers for Toxicity and Efficacy in Patients With mccRCC Treated by Anti-VEGF Therapy (METASUN)

Clear-cell Metastatic Renal Cell Carcinoma

Belgium
AVEO Pharmaceuticals, Inc.
Astellas Pharma Inc

Terminated

A Subject Treatment Preference Study of Tivozanib Versus Sunitinib in Subjects With Metastatic RCC (TAURUS)

Metastatic Renal Cell Carcinoma

France, United Kingdom, Germany, Spain, Belgium, United States, Italy

Search clinical trials for: Modulation of FiO2

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Pakistan

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations